Eryilmaz, M. K. Et Al. 2016. Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.6 , 806-810.

Eryilmaz, M. K., Mutlu, H., Salim, D. K., Musri, F. Y., & COŞKUN, H. Ş., (2016). Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.6, 806-810.

Eryilmaz, Melek Et Al. "Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.6, 806-810, 2016

Eryilmaz, Melek K. Et Al. "Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.6, pp.806-810, 2016

Eryilmaz, M. K. Et Al. (2016) . "Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.6, pp.806-810.

@article{article, author={Melek Karakurt Eryilmaz Et Al. }, title={Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2016, pages={806-810} }